Evolus Inc (EOLS)

Mar 28, 2025

Evolus CEO David Moatazedi sells $77,512 in stock By Investing.com - Investing.com Australia

Mar 28, 2025

Mar 28, 2025

Evolus CEO David Moatazedi sells $77,512 in stock - Investing.com India

Mar 28, 2025

Mar 25, 2025

Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - BioSpace

Mar 25, 2025

Mar 25, 2025

Evolus Inc (EOLS) Shares Down 4.54% on Mar 25 - GuruFocus

Mar 25, 2025

Mar 25, 2025

Evolus Leadership Reveals Growth Strategy at Major Healthcare Conference - Stock Titan

Mar 25, 2025

Mar 24, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 21, 2025 - BioSpace

Mar 24, 2025

Mar 23, 2025

Investing in Evolus (NASDAQ:EOLS) five years ago would have delivered you a 216% gain - Yahoo Finance

Mar 23, 2025

Mar 21, 2025

Evolus reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 21, 2025 at 04:17 pm EDT - MarketScreener

Mar 21, 2025

Mar 21, 2025

Evolus director David Moatazedi sells $1.37 million in stock By Investing.com - Investing.com Australia

Mar 21, 2025

Mar 21, 2025

Evolus Growth Continues: 14 New Employees Join as Company Strengthens Talent Pool - Stock Titan

Mar 21, 2025

Mar 21, 2025

Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference - Business Wire

Mar 21, 2025

Mar 20, 2025

Evolus executive Avelar Rui sells $369,867 in stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock - Investing.com

Mar 20, 2025

Mar 20, 2025

Evolus executive Avelar Rui sells $369,867 in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

Evolus director David Moatazedi sells $1.37 million in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock - Investing.com

Mar 20, 2025

Mar 20, 2025

When the Price of (EOLS) Talks, People Listen - news.stocktradersdaily.com

Mar 20, 2025

Mar 20, 2025

Evolus Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 20, 2025

Mar 16, 2025

Trade Alert: Independent Director Of Evolus Karah Parschauer Has Sold Stock - Simply Wall St

Mar 16, 2025

Mar 15, 2025

Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting - Business Wire

Mar 15, 2025

Mar 14, 2025

Evolus director Parschauer sells $167,465 in common stock - Investing.com India

Mar 14, 2025

Mar 14, 2025

Evolus director Parschauer sells $167,465 in common stock By Investing.com - Investing.com South Africa

Mar 14, 2025

Mar 13, 2025

Evolus’s SWOT analysis: fda approval boosts stock as dermal filler market expands - Investing.com India

Mar 13, 2025

Mar 12, 2025

Evolus’s SWOT analysis: fda approval boosts stock as dermal filler market expands By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 12, 2025

Evolus at Barclays Conference: Strategic Growth and New Launch - Investing.com

Mar 12, 2025

Mar 11, 2025

Evolus at Leerink’s Global Healthcare Conference: Strategic Growth Insights - Investing.com India

Mar 11, 2025

Mar 11, 2025

Evolus at Leerink’s Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 10, 2025

Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas - The Motley Fool

Mar 10, 2025

Mar 10, 2025

What is HC Wainwright’s Estimate for Evolus FY2025 Earnings? - Defense World

Mar 10, 2025

Mar 09, 2025

(EOLS) Investment Analysis - Stock Traders Daily

Mar 09, 2025

Mar 09, 2025

Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty - MSN

Mar 09, 2025

Mar 08, 2025

Global Jeuveau Market Outlook 2025-2034: Growth Drivers, Share, And Trends - EIN News

Mar 08, 2025

Mar 08, 2025

Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Principal Financial Group Inc. - Defense World

Mar 08, 2025

Mar 07, 2025

Evolus, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Rhumbline Advisers - Defense World

Mar 07, 2025

Mar 07, 2025

IFP Advisors Inc Has $52,000 Position in Evolus, Inc. (NASDAQ:EOLS) - Defense World

Mar 07, 2025

Mar 07, 2025

Evolus’s Strong Market Position and Growth Potential Highlighted by Robust Revenues and Strategic Expansions - TipRanks

Mar 07, 2025

Mar 07, 2025

HC Wainwright Reaffirms “Buy” Rating for Evolus (NASDAQ:EOLS) - Defense World

Mar 07, 2025

Mar 06, 2025

Evolus’s Promising Growth and Strategic Positioning Earns a ‘Buy’ Rating from Analyst Douglas Tsao - TipRanks

Mar 06, 2025

Mar 05, 2025

Evolus, Inc. Earnings Call Highlights Robust Growth and Profitability - TipRanks

Mar 05, 2025

Mar 05, 2025

Evolus Inc Reports Q4 2024 Revenue of $79 Million, Surpassing Es - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

Stifel maintains Buy on Evolus stock, sets $25 target By Investing.com - Investing.com UK

Mar 05, 2025

Mar 05, 2025

H.C. Wainwright maintains Buy rating on Evolus stock at $27 target By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

H.C. Wainwright maintains Buy rating on Evolus stock at $27 target - Investing.com

Mar 05, 2025

Mar 05, 2025

Evolus Celebrates Strong Demand For Jeuveau Wrinkle Treatment - Finimize

Mar 05, 2025

Mar 05, 2025

Assessing Evolus: Insights From 6 Financial Analysts - Benzinga

Mar 05, 2025

Mar 05, 2025

Evolus price target raised to $25 from $22 at Barclays - TipRanks

Mar 05, 2025

Mar 05, 2025

Evolus reports Q4 EPS (11c) vs (21c) last year - TipRanks

Mar 05, 2025